Table 2 Scores in Self-efficacy (GSE), Quality of Life Scale (QOLS-N) and Coping Strategies Scale before the intervention, at the end of the intervention, and six months after the end of the intervention for the treatment (N = 41) and control (N = 28) groups (mean ± SD).1
Variables | Score before (SB) | Score after (SA) | D.F | F (SA-SB) | P | Score six months after end of intervention (SSMA) | D.F | F (SSMA-SB) | P | D.F. | F (SSMA-SA) | P |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Self-efficacy (GSE) | ||||||||||||
Treatment group | 23.1 ± 5.12 | 23.5 ± 6.56 | 1,60 | 0.02 | n.s. | 25.7 ± 5.93 | 1,55 | 4.20 | 0.05 | 1,55 | 5.6 | 0.02 |
Control group | 25.6 ± 6.40 | 25.3 ± 6.62 | 25.4 ± 5.92 | |||||||||
Quality of Life Scale (QOLS-N) | ||||||||||||
Treatment group | 64.3 ± 14.93 | 64.3 ± 17.09 | 1,60 | 0.49 | n.s. | 66.7 ± 16.86 | 1,57 | 0.38 | n.s | 1,57 | 0.38 | n.s |
Control group | 63.2 ± 14.06 | 64.4 ± 13.52 | 66.0 ± 15.25 | |||||||||
Coping Strategies Scale | ||||||||||||
Treatment group | 31.6 ± 8.51 | 32.8 ± 8.67 | 1,60 | 0.01 | n.s. | 34.3 ± 8.10 | 1,57 | 0.79 | n.s. | 1,57 | 0.39 | n.s |
Control group | 32.2 ± 7.38 | 31.4 ± 8.69 | 31.6 ± 8.02 |